Copyright
©The Author(s) 2017.
World J Crit Care Med. May 4, 2017; 6(2): 116-123
Published online May 4, 2017. doi: 10.5492/wjccm.v6.i2.116
Published online May 4, 2017. doi: 10.5492/wjccm.v6.i2.116
Variable, n (%) | ICU group | Non ICU group | P value |
n = 51 | n =119 | ||
Age, mean (SD) | 56.6 (12.8) | 54.5 (10.5) | 0.282 |
ASA, mean (SD) | 3.1 (0.6) | 2.8 (0.5) | 0.009 |
ASA, > 3 (%) | 12 (24) | 8 (6.7) | < 0.001 |
Intraop PCI, mean (SD) | 21.5 (8.4) | 13.7 (8.3) | < 0.001 |
Change in PCI, mean (SD) | 16.2 (7.1) | 10.7 (6.1) | < 0.001 |
No. of resected organs: Mean (SD) | 5.9 (2.2) | 3.1 (2.1) | < 0.001 |
EBL, mean (SD) | 1505 (1408) | 423 (519) | < 0.001 |
Intraop transfusion (%) | 45 (90) | 26 (21.7) | < 0.001 |
OR time, min, mean (SD) | 456 (122) | 328 (118) | < 0.001 |
Mortality at | |||
30 d (%) | 2 (4) | 2 (1.7) | 0.36 |
90 d (%) | 8 (12) | 6 (5) | 0.104 |
Hospital stay, mean (range) | 18 (5-88) | 8.6 (3-101) | < 0.001 |
Survival, mo: Median (SE) | 14 (1.8) | 33.4 (5.3) | < 0.001 |
Readmission rate to ICU (%) | 6/51 (12) | 3/119 (2.5) | 0.01 |
- Citation: Kapoor S, Bassily-Marcus A, Alba Yunen R, Tabrizian P, Semoin S, Blankush J, Labow D, Oropello J, Manasia A, Kohli-Seth R. Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. World J Crit Care Med 2017; 6(2): 116-123
- URL: https://www.wjgnet.com/2220-3141/full/v6/i2/116.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v6.i2.116